rs587777417
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_139242.4(MTFMT):c.146_153delGGGTGCTC(p.Arg49fs) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000507 in 1,379,580 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000051 ( 0 hom. )
Consequence
MTFMT
NM_139242.4 frameshift
NM_139242.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.08
Genes affected
MTFMT (HGNC:29666): (mitochondrial methionyl-tRNA formyltransferase) The protein encoded by this nuclear gene localizes to the mitochondrion, where it catalyzes the formylation of methionyl-tRNA. [provided by RefSeq, Jun 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-65029460-AGAGCACCC-A is Pathogenic according to our data. Variant chr15-65029460-AGAGCACCC-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 133323.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTFMT | NM_139242.4 | c.146_153delGGGTGCTC | p.Arg49fs | frameshift_variant | 1/9 | ENST00000220058.9 | NP_640335.2 | |
MTFMT | XM_005254158.6 | c.146_153delGGGTGCTC | p.Arg49fs | frameshift_variant | 1/9 | XP_005254215.2 | ||
MTFMT | XR_001751081.2 | n.172_179delGGGTGCTC | non_coding_transcript_exon_variant | 1/5 | ||||
MTFMT | XR_007064421.1 | n.172_179delGGGTGCTC | non_coding_transcript_exon_variant | 1/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTFMT | ENST00000220058.9 | c.146_153delGGGTGCTC | p.Arg49fs | frameshift_variant | 1/9 | 1 | NM_139242.4 | ENSP00000220058.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000825 AC: 1AN: 121226Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66662
GnomAD3 exomes
AF:
AC:
1
AN:
121226
Hom.:
AF XY:
AC XY:
0
AN XY:
66662
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000507 AC: 7AN: 1379580Hom.: 0 AF XY: 0.00000588 AC XY: 4AN XY: 680530
GnomAD4 exome
AF:
AC:
7
AN:
1379580
Hom.:
AF XY:
AC XY:
4
AN XY:
680530
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 19, 2024 | PP1, PM2, PM3_supporting, PVS1 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2017 | - - |
Combined oxidative phosphorylation defect type 15 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at